COVID-19 Impact on Global Congenital Heart Disease Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 129 pages | ID: CA35991A2028EN
QYResearch

Abstracts

This report focuses on the global Congenital Heart Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Congenital Heart Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Novartis
• Abbott Laboratories
• Roche
• GSK
• Sanofi
• Johnson & Johnson
• Medtronic
• BD
• Boston Scientific
• Merck
• Eli Lilly
• Mylan
• Sun Pharmaceutical
• AstraZeneca

Market segment by Type, the product can be split into

• Medication
• Surgical Therapy

Market segment by Application, split into

• Hospitals and Clinics
• Diagnostic Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Congenital Heart Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Congenital Heart Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Congenital Heart Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Congenital Heart Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Congenital Heart Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Medication
  1.4.3 Surgical Therapy
1.5 Market by Application
  1.5.1 Global Congenital Heart Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Diagnostic Centers
1.6 Coronavirus Disease 2019 (Covid-19): Congenital Heart Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Congenital Heart Disease Treatment Industry
    1.6.1.1 Congenital Heart Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Congenital Heart Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Congenital Heart Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Congenital Heart Disease Treatment Market Perspective (2015-2026)
2.2 Congenital Heart Disease Treatment Growth Trends by Regions
  2.2.1 Congenital Heart Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Congenital Heart Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Congenital Heart Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Congenital Heart Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Congenital Heart Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Congenital Heart Disease Treatment Players by Market Size
  3.1.1 Global Top Congenital Heart Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Congenital Heart Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Congenital Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Congenital Heart Disease Treatment Market Concentration Ratio
  3.2.1 Global Congenital Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Treatment Revenue in 2019
3.3 Congenital Heart Disease Treatment Key Players Head office and Area Served
3.4 Key Players Congenital Heart Disease Treatment Product Solution and Service
3.5 Date of Enter into Congenital Heart Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Congenital Heart Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Congenital Heart Disease Treatment Forecasted Market Size by Type (2021-2026)

5 CONGENITAL HEART DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Congenital Heart Disease Treatment Market Size by Application (2015-2020)
5.2 Global Congenital Heart Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Congenital Heart Disease Treatment Market Size (2015-2020)
6.2 Congenital Heart Disease Treatment Key Players in North America (2019-2020)
6.3 North America Congenital Heart Disease Treatment Market Size by Type (2015-2020)
6.4 North America Congenital Heart Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Congenital Heart Disease Treatment Market Size (2015-2020)
7.2 Congenital Heart Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Congenital Heart Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Congenital Heart Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Congenital Heart Disease Treatment Market Size (2015-2020)
8.2 Congenital Heart Disease Treatment Key Players in China (2019-2020)
8.3 China Congenital Heart Disease Treatment Market Size by Type (2015-2020)
8.4 China Congenital Heart Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Congenital Heart Disease Treatment Market Size (2015-2020)
9.2 Congenital Heart Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Congenital Heart Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Congenital Heart Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Congenital Heart Disease Treatment Market Size (2015-2020)
10.2 Congenital Heart Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Congenital Heart Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Congenital Heart Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Congenital Heart Disease Treatment Market Size (2015-2020)
11.2 Congenital Heart Disease Treatment Key Players in India (2019-2020)
11.3 India Congenital Heart Disease Treatment Market Size by Type (2015-2020)
11.4 India Congenital Heart Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Congenital Heart Disease Treatment Market Size (2015-2020)
12.2 Congenital Heart Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Congenital Heart Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Congenital Heart Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Congenital Heart Disease Treatment Introduction
  13.1.4 Pfizer Revenue in Congenital Heart Disease Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Congenital Heart Disease Treatment Introduction
  13.2.4 Novartis Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Abbott Laboratories
  13.3.1 Abbott Laboratories Company Details
  13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.3.3 Abbott Laboratories Congenital Heart Disease Treatment Introduction
  13.3.4 Abbott Laboratories Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.3.5 Abbott Laboratories Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Congenital Heart Disease Treatment Introduction
  13.4.4 Roche Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 GSK
  13.5.1 GSK Company Details
  13.5.2 GSK Business Overview and Its Total Revenue
  13.5.3 GSK Congenital Heart Disease Treatment Introduction
  13.5.4 GSK Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.5.5 GSK Recent Development
13.6 Sanofi
  13.6.1 Sanofi Company Details
  13.6.2 Sanofi Business Overview and Its Total Revenue
  13.6.3 Sanofi Congenital Heart Disease Treatment Introduction
  13.6.4 Sanofi Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.6.5 Sanofi Recent Development
13.7 Johnson & Johnson
  13.7.1 Johnson & Johnson Company Details
  13.7.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.7.3 Johnson & Johnson Congenital Heart Disease Treatment Introduction
  13.7.4 Johnson & Johnson Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.7.5 Johnson & Johnson Recent Development
13.8 Medtronic
  13.8.1 Medtronic Company Details
  13.8.2 Medtronic Business Overview and Its Total Revenue
  13.8.3 Medtronic Congenital Heart Disease Treatment Introduction
  13.8.4 Medtronic Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.8.5 Medtronic Recent Development
13.9 BD
  13.9.1 BD Company Details
  13.9.2 BD Business Overview and Its Total Revenue
  13.9.3 BD Congenital Heart Disease Treatment Introduction
  13.9.4 BD Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.9.5 BD Recent Development
13.10 Boston Scientific
  13.10.1 Boston Scientific Company Details
  13.10.2 Boston Scientific Business Overview and Its Total Revenue
  13.10.3 Boston Scientific Congenital Heart Disease Treatment Introduction
  13.10.4 Boston Scientific Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  13.10.5 Boston Scientific Recent Development
13.11 Merck
  10.11.1 Merck Company Details
  10.11.2 Merck Business Overview and Its Total Revenue
  10.11.3 Merck Congenital Heart Disease Treatment Introduction
  10.11.4 Merck Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  10.11.5 Merck Recent Development
13.12 Eli Lilly
  10.12.1 Eli Lilly Company Details
  10.12.2 Eli Lilly Business Overview and Its Total Revenue
  10.12.3 Eli Lilly Congenital Heart Disease Treatment Introduction
  10.12.4 Eli Lilly Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  10.12.5 Eli Lilly Recent Development
13.13 Mylan
  10.13.1 Mylan Company Details
  10.13.2 Mylan Business Overview and Its Total Revenue
  10.13.3 Mylan Congenital Heart Disease Treatment Introduction
  10.13.4 Mylan Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  10.13.5 Mylan Recent Development
13.14 Sun Pharmaceutical
  10.14.1 Sun Pharmaceutical Company Details
  10.14.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  10.14.3 Sun Pharmaceutical Congenital Heart Disease Treatment Introduction
  10.14.4 Sun Pharmaceutical Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  10.14.5 Sun Pharmaceutical Recent Development
13.15 AstraZeneca
  10.15.1 AstraZeneca Company Details
  10.15.2 AstraZeneca Business Overview and Its Total Revenue
  10.15.3 AstraZeneca Congenital Heart Disease Treatment Introduction
  10.15.4 AstraZeneca Revenue in Congenital Heart Disease Treatment Business (2015-2020)
  10.15.5 AstraZeneca Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Congenital Heart Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Congenital Heart Disease Treatment Revenue
Table 3. Ranking of Global Top Congenital Heart Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Congenital Heart Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medication
Table 6. Key Players of Surgical Therapy
Table 7. COVID-19 Impact Global Market: (Four Congenital Heart Disease Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Congenital Heart Disease Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Congenital Heart Disease Treatment Players to Combat Covid-19 Impact
Table 12. Global Congenital Heart Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Congenital Heart Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Congenital Heart Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Congenital Heart Disease Treatment Market Share by Regions (2015-2020)
Table 16. Global Congenital Heart Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Congenital Heart Disease Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Congenital Heart Disease Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Congenital Heart Disease Treatment Players
Table 23. Global Congenital Heart Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Congenital Heart Disease Treatment Market Share by Players (2015-2020)
Table 25. Global Top Congenital Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease Treatment as of 2019)
Table 26. Global Congenital Heart Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Congenital Heart Disease Treatment Product Solution and Service
Table 29. Date of Enter into Congenital Heart Disease Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Congenital Heart Disease Treatment Market Size Share by Type (2015-2020)
Table 33. Global Congenital Heart Disease Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Congenital Heart Disease Treatment Market Size Share by Application (2015-2020)
Table 35. Global Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Congenital Heart Disease Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 39. North America Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 41. North America Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 45. Europe Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 47. Europe Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 51. China Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 53. China Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 57. Japan Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 59. Japan Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 63. Southeast Asia Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 69. India Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 71. India Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Congenital Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Congenital Heart Disease Treatment Market Share (2019-2020)
Table 75. Central & South America Congenital Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Congenital Heart Disease Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Congenital Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Congenital Heart Disease Treatment Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 93. Abbott Laboratories Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. GSK Company Details
Table 100. GSK Business Overview
Table 101. GSK Product
Table 102. GSK Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 103. GSK Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Product
Table 112. Johnson & Johnson Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 113. Johnson & Johnson Recent Development
Table 114. Medtronic Business Overview
Table 115. Medtronic Product
Table 116. Medtronic Company Details
Table 117. Medtronic Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 118. Medtronic Recent Development
Table 119. BD Company Details
Table 120. BD Business Overview
Table 121. BD Product
Table 122. BD Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 123. BD Recent Development
Table 124. Boston Scientific Company Details
Table 125. Boston Scientific Business Overview
Table 126. Boston Scientific Product
Table 127. Boston Scientific Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 128. Boston Scientific Recent Development
Table 129. Merck Company Details
Table 130. Merck Business Overview
Table 131. Merck Product
Table 132. Merck Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 133. Merck Recent Development
Table 134. Eli Lilly Company Details
Table 135. Eli Lilly Business Overview
Table 136. Eli Lilly Product
Table 137. Eli Lilly Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 138. Eli Lilly Recent Development
Table 139. Mylan Company Details
Table 140. Mylan Business Overview
Table 141. Mylan Product
Table 142. Mylan Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 143. Mylan Recent Development
Table 144. Sun Pharmaceutical Company Details
Table 145. Sun Pharmaceutical Business Overview
Table 146. Sun Pharmaceutical Product
Table 147. Sun Pharmaceutical Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 148. Sun Pharmaceutical Recent Development
Table 149. AstraZeneca Company Details
Table 150. AstraZeneca Business Overview
Table 151. AstraZeneca Product
Table 152. AstraZeneca Revenue in Congenital Heart Disease Treatment Business (2015-2020) (Million US$)
Table 153. AstraZeneca Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Congenital Heart Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medication Features
Figure 3. Surgical Therapy Features
Figure 4. Global Congenital Heart Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Congenital Heart Disease Treatment Report Years Considered
Figure 8. Global Congenital Heart Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Congenital Heart Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Congenital Heart Disease Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Congenital Heart Disease Treatment Market Share by Players in 2019
Figure 13. Global Top Congenital Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Congenital Heart Disease Treatment Revenue in 2019
Figure 15. North America Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Congenital Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Pfizer Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 26. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Laboratories Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 30. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GSK Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 32. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sanofi Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 34. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Johnson & Johnson Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 36. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Medtronic Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 38. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. BD Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 40. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Boston Scientific Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 42. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Merck Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 44. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Eli Lilly Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 46. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Mylan Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 48. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AstraZeneca Revenue Growth Rate in Congenital Heart Disease Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed